HRES 928 · 119th CongressIn Committeecongress.gov ↗
Affirming support for most-favored-Nation drug pricing for United States patients.
What this bill does
AI plain-language summaryThis bill appears to support giving United States patients access to drug pricing that matches the best prices other countries receive, known as "most-favored-nation" pricing. No official summary is available for this bill.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.